Provided by Tiger Trade Technology Pte. Ltd.

DaVita HealthCare Partners

173.82
-1.4200-0.81%
Post-market: 174.350.5300+0.30%19:53 EDT
Volume:633.63K
Turnover:110.62M
Market Cap:11.16B
PE:14.33
High:176.19
Open:175.25
Low:173.74
Close:175.24
52wk High:247.49
52wk Low:101.00
Shares:64.20M
Float Shares:32.63M
Volume Ratio:1.32
T/O Rate:1.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):12.13
EPS(LYR):9.84
ROE:88.48%
ROA:7.52%
PB:-14.59
PE(LYR):17.67

Loading ...

BofA Adjusts Price Target on DaVita to $170 From $145

MT Newswires Live
·
Aug 05

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), Syndax Pharmaceuticals (SNDX) and DaVita (DVA)

TIPRANKS
·
Aug 05

U.S. Stocks on the MOVE-Arista Networks, CVS, Eli Lilly, Phillips 66

Reuters
·
Aug 05

DaVita, Inc. : Deutsche Bank Raises Target Price to $265 from $220

THOMSON REUTERS
·
Aug 05

CVS Health Q2 Revenue Beats Estimates, Outlook Raised

Reuters
·
Aug 05

Movement Alert|DaVita HealthCare Partners Falls 5.94% in Pre-Market Trading, Q2 Beat Overshadowed by Unchanged Full-Year Guidance

Market Focus
·
Aug 05

Barclays Sticks to Its Hold Rating for DaVita (DVA)

TIPRANKS
·
Aug 05

Movement Alert|DaVita HealthCare Partners Declines 5.83% Overnight, Q2 Beat Overshadowed by Unchanged Full-Year Guidance

Market Focus
·
Aug 05

Stock Track | DaVita HealthCare Partners Plunges 5.83% in Post-Market as Unchanged Full-Year Guidance Disappoints Despite Q2 Beat

Stock Track
·
Aug 05

DaVita Flags Lower Revenue Per Treatment, Reaffirms Annual Forecast

Reuters
·
Aug 05

DaVita Q2 FY26 Operating Income Climbs 20.1% to $579 Million; Revenue Rises 4% to $3.55 Billion

Reuters
·
Aug 05

DaVita Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Berkshire Sells 182,980 DaVita Shares, Still Has 45% Stake in Dialysis Provider

Reuters
·
Aug 05

Berkshire Hathaway Sells 182,980 DaVita Shares at an Average $199.55 Each, Still Owns About 28.7 Million DaVita Shares, SEC Filing Shows

THOMSON REUTERS
·
Aug 05

DaVita Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 05

Movement Alert|DaVita HealthCare Partners Falls 6.14% in After-Hours Trading, Q2 Beat Overshadowed by Unchanged Full-Year Guidance

Market Focus
·
Aug 05

Stock Track | DaVita HealthCare Partners Plunges 5.26% After-Hours as Full-Year Guidance Misses Estimates Despite Q2 Beat

Stock Track
·
Aug 05

GUIDANCE: (DVA) DaVita Expects Full Year 2026 Adjusted EPS Range $14.10 - $15.20, vs. FactSet Est of $14.88

MT Newswires Live
·
Aug 05

Dialysis Provider DaVita's Q2 Results Beat Estimates, Aided by Higher Average Rates

Reuters
·
Aug 05

DaVita Q2 Adj. EPS $4.02 Beats $3.88 Estimate, Sales $3.554B Beat $3.496B Estimate

Benzinga Earnings
·
Aug 05